Analysis

Theracryf Plc (TCF) Stock Analysis

Theracryf Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to TCF.

websiteTCF/analysis/TCF

Theracryf Plc

Theracryf Plc investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TCF.

Stock profile

Ticker

TCF

Asset type

Stock

Market cap

$6.7M

Sector

Health Services

Industry

Medical/Nursing Services

Currency

GBX

Ticker listings

Theracryf Plc may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TCF primary listing
  • 8EV

Latest Theracryf Plc news

Positive Ox-1 tox data in addiction programme

TheraCryf plc announced positive top-line data from the first toxicology species in its lead Ox-1 addiction program, with the drug well-tolerated at doses 100 times the expected...

Investor Webinar

TheraCryf plc will host an investor webinar on April 24, 2026, at 10:00 am BST, featuring the CEO and COO to discuss progress in their lead orexin-1 receptor antagonist program ...

Successful GMP Manufacture Advances Ox-1 to Clinic

TheraCryf plc has successfully manufactured over 2kg of its lead asset, Ox-1 receptor antagonist, to Good Manufacturing Practice (GMP) standard, producing 2.57kg of human-grade ...

New Manufacturing Process Patent for Ox-1

TheraCryf plc has filed a new process patent for its lead asset, Ox-1, a selective orexin-1 receptor antagonist for addiction, which, if granted, could extend commercial exclusi...

Non-Binding Proposal to Acquire TheraCryf’s Assets

TheraCryf plc announced it received a conditional, non-binding proposal to acquire its lead neuropsychiatry assets, the Orexin-1 and dopamine transporter programmes, but the Boa...

Research sections

Valuation

Review valuation context for Theracryf Plc.

Future growth

Review future growth context for Theracryf Plc.

Past performance

Review past performance context for Theracryf Plc.

Financial health

Review financial health context for Theracryf Plc.

Dividend

Review dividend context for Theracryf Plc.

Management

Review management context for Theracryf Plc.

Ownership

Review ownership context for Theracryf Plc.

Other information

Review other information context for Theracryf Plc.

Community

Review community context for Theracryf Plc.